Inogen (INGN) Misses Q4 EPS by 26c

Inogen (NASDAQ: INGN) reported Q4 EPS of ($1.01), $0.26 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $76.4 million versus the consensus estimate of $75.15 million.

For earnings history and earnings-related data on Inogen (INGN) click here.

You May Also Be Interested In

• Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
• SBC Medical Group Holdings Incorporated (SBC) Misses Q2 EPS by 2c
• Applied Industrial Technologies (AIT) Tops Q4 EPS by 25c, Beats on Revenue; Offers FY27 EPS Guidance